<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00638014</url>
  </required_header>
  <id_info>
    <org_study_id>PRO00006260</org_study_id>
    <nct_id>NCT00638014</nct_id>
  </id_info>
  <brief_title>Rapid Sternal Closure System (TALON)</brief_title>
  <acronym>TALON</acronym>
  <official_title>A Randomized, Controlled, Phase 4 Study of Sternal Plating (Rapid Sternal Closure System, KLS Martin L.P.) in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Complications.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KLS Martin, L.P.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to establish if the Rapid Sternal Closure System (RSCS) improves
      early postoperative recovery as manifested by decreased pain and improved pulmonary function.

      Secondary objectives include evaluation of Rapid Sternal Closure System with regard to SWCs
      (surgical wound complication defined as surgically treated sternal wound infection and
      sternal instability/non-union) as outlined in the protocol.

      For a given study endpoint, the null hypothesis will be no difference between the Rapid
      Sternal Closure System group and the control group. The alternative hypothesis will be a
      difference between 2 groups. The statistical objective of this study is to reject the null
      hypothesis in favor of the alternative hypothesis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage Change of Preoperative Incentive Spirometry (IS) Volume Achieved</measure>
    <time_frame>Baseline, Maximum value during postoperatively days 1 thru 7</time_frame>
    <description>Maximum incentive spirometry volume was measured at baseline (prior to surgery) and daily from postoperative day 1 through postoperative day 7 (or discharge if earlier) using a Coach 2 incentive spirometer with one way valve (Coach 2 model # 22-4000, Smiths Medical, Keene, NH).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Sternal Wound Infection or Sternal Instability/Non-union</measure>
    <time_frame>Up to 180 days</time_frame>
    <description>The Data and Safety Monitoring Board reviewed source documents for all cases with possible sternal wound infection and sternal instability or non-union and made a determination as to the presence of these complications.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Sternal Wound Infection</condition>
  <condition>Mediastinitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional wires only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Rapid Sternal Closure System supplemented with wires</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Rapid Sternal Closure System</intervention_name>
    <description>Sternal talons will be used and supplemented with wires</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional wire closure</intervention_name>
    <description>Conventional wire closure of sternum</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female. Women of childbearing potential must have a negative serum (or urine)
             human chorionic gonadotropin assay prior to surgery, and be willing to continue to use
             effective means of birth control for at least 180 days following surgery. Medically
             acceptable contraceptives include: (1) surgical sterilization (such as a tubal
             ligation or hysterectomy), (2) approved hormonal contraceptives (such as birth control
             pills, patches, implants or injections), (3) barrier methods (such as a condom or
             diaphragm) used with a spermicide, or (4) an intrauterine device (IUD). Contraceptive
             measures such as Plan B(TM), sold for emergency use after unprotected sex, are not
             acceptable methods for routine use.

          2. Age ≥ 18 years.

          3. Scheduled to undergo nonemergent on or off pump coronary artery bypass graft (CABG)
             and/or valve repair or replacement surgery through a full median sternotomy.

          4. At higher risk for SWC, defined as the presence of any of the following factors:
             obesity (body mass index &gt; 30), chronic steroid use (&gt;6 month duration and currently
             using), severe chronic obstructive pulomonary disease, planned bilateral internal
             mammary artery harvest, undergoing redo median sternotomy, and history of radiation to
             the chest.

          5. Willing and able to provide written informed consent.

          6. Available for evaluation from baseline until final evaluation at 180 days postsurgery.

        Exclusion Criteria:

          1. Undergoing emergency cardiac surgery (urgent surgery is allowed if informed consent is
             obtained and the study procedures can be performed).

          2. Undergoing a significant concomitant surgical procedure (eg, carotid endarterectomy,
             aortic root repair or replacement, deep hypothermic circulatory arrest [DHCA], or
             pulmonary resection).

          3. Undergoing a minimally invasive or a thoracic surgical approach.

          4. Using a preoperative mechanical assist device or intraaortic balloon pump (IABP), if
             inserted for shock/low output syndrome (an IABP is allowed if it is inserted for
             unstable angina or low ejection fraction).

          5. Active and significant systemic infection, eg, active endocarditis or a history of
             significant recurrent systemic infection.

          6. Receiving antibiotic therapy within the 2 weeks before the date of surgery.

          7. History of malignancy within the past year (except for squamous or basal cell
             carcinoma of the skin that has been treated, with no evidence of recurrence).

          8. History of major organ transplantation, including bone marrow transplantation.

          9. Recent history of significant drug or alcohol abuse.

         10. Current immunosuppressive condition (eg, symptomatic human immunodeficiency virus
             [HIV] infection). Use of steroids is not an exclusion criteria).

         11. Female subject who is pregnant (including a positive pregnancy test at screening or
             baseline) or nursing. Females of childbearing potential not practicing a birth control
             method with a high degree of reliability.

         12. Postsurgical life expectancy ≤ 90 days, in the investigator's or sponsor's opinion.

         13. Current participation or participation within 30 days before the start of this study
             in an experimental drug or device study or currently participating in a study during
             which the administration of investigational drugs within 90 days is anticipated.

         14. Refusal to accept medically indicated blood products.

         15. Moderate or severe pectus deformity.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elliott Bennett-Guerrero, M. D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Fry DE. The economic costs of surgical site infection. Surg Infect (Larchmt). 2002;3 Suppl 1:S37-43. Review.</citation>
    <PMID>12573038</PMID>
  </reference>
  <reference>
    <citation>Friberg O, Dahlin LG, Levin LA, Magnusson A, Granfeldt H, Källman J, Svedjeholm R. Cost effectiveness of local collagen-gentamicin as prophylaxis for sternal wound infections in different risk groups. Scand Cardiovasc J. 2006 Apr;40(2):117-25.</citation>
    <PMID>16608782</PMID>
  </reference>
  <reference>
    <citation>Demmy TL, Park SB, Liebler GA, Burkholder JA, Maher TD, Benckart DH, Magovern GJ Jr, Magovern GJ Sr. Recent experience with major sternal wound complications. Ann Thorac Surg. 1990 Mar;49(3):458-62.</citation>
    <PMID>2310254</PMID>
  </reference>
  <reference>
    <citation>Tang GH, Maganti M, Weisel RD, Borger MA. Prevention and management of deep sternal wound infection. Semin Thorac Cardiovasc Surg. 2004 Spring;16(1):62-9. Review.</citation>
    <PMID>15366689</PMID>
  </reference>
  <reference>
    <citation>Braxton JH, Marrin CA, McGrath PD, Morton JR, Norotsky M, Charlesworth DC, Lahey SJ, Clough R, Ross CS, Olmstead EM, O'Connor GT. 10-year follow-up of patients with and without mediastinitis. Semin Thorac Cardiovasc Surg. 2004 Spring;16(1):70-6.</citation>
    <PMID>15366690</PMID>
  </reference>
  <reference>
    <citation>Hollenbeak CS, Murphy DM, Koenig S, Woodward RS, Dunagan WC, Fraser VJ. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest. 2000 Aug;118(2):397-402.</citation>
    <PMID>10936131</PMID>
  </reference>
  <reference>
    <citation>Boyce JM, Potter-Bynoe G, Dziobek L. Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol. 1990 Feb;11(2):89-93.</citation>
    <PMID>2107250</PMID>
  </reference>
  <reference>
    <citation>Baskett RJ, MacDougall CE, Ross DB. Is mediastinitis a preventable complication? A 10-year review. Ann Thorac Surg. 1999 Feb;67(2):462-5.</citation>
    <PMID>10197671</PMID>
  </reference>
  <reference>
    <citation>Sakamoto H, Fukuda I, Oosaka M, Nakata H. Risk factors and treatment of deep sternal wound infection after cardiac operation. Ann Thorac Cardiovasc Surg. 2003 Aug;9(4):226-32.</citation>
    <PMID>13129420</PMID>
  </reference>
  <reference>
    <citation>Crabtree TD, Codd JE, Fraser VJ, Bailey MS, Olsen MA, Damiano RJ Jr. Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypass grafting at a tertiary care medical center. Semin Thorac Cardiovasc Surg. 2004 Spring;16(1):53-61.</citation>
    <PMID>15366688</PMID>
  </reference>
  <reference>
    <citation>Fowler VG Jr, O'Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED. Clinical predictors of major infections after cardiac surgery. Circulation. 2005 Aug 30;112(9 Suppl):I358-65.</citation>
    <PMID>16159846</PMID>
  </reference>
  <reference>
    <citation>Olsen MA, Lock-Buckley P, Hopkins D, Polish LB, Sundt TM, Fraser VJ. The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg. 2002 Jul;124(1):136-45.</citation>
    <PMID>12091819</PMID>
  </reference>
  <reference>
    <citation>Ridderstolpe L, Gill H, Granfeldt H, Ahlfeldt H, Rutberg H. Superficial and deep sternal wound complications: incidence, risk factors and mortality. Eur J Cardiothorac Surg. 2001 Dec;20(6):1168-75.</citation>
    <PMID>11717023</PMID>
  </reference>
  <reference>
    <citation>Trick WE, Scheckler WE, Tokars JI, Jones KC, Reppen ML, Smith EM, Jarvis WR. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2000 Jan;119(1):108-14.</citation>
    <PMID>10612768</PMID>
  </reference>
  <reference>
    <citation>Abboud CS, Wey SB, Baltar VT. Risk factors for mediastinitis after cardiac surgery. Ann Thorac Surg. 2004 Feb;77(2):676-83.</citation>
    <PMID>14759458</PMID>
  </reference>
  <reference>
    <citation>Dodds Ashley ES, Carroll DN, Engemann JJ, Harris AD, Fowler VG Jr, Sexton DJ, Kaye KS. Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2004 Jun 1;38(11):1555-60. Epub 2004 May 12.</citation>
    <PMID>15156442</PMID>
  </reference>
  <reference>
    <citation>Lu JC, Grayson AD, Jha P, Srinivasan AK, Fabri BM. Risk factors for sternal wound infection and mid-term survival following coronary artery bypass surgery. Eur J Cardiothorac Surg. 2003 Jun;23(6):943-9.</citation>
    <PMID>12829070</PMID>
  </reference>
  <reference>
    <citation>Jonkers D, Elenbaas T, Terporten P, Nieman F, Stobberingh E. Prevalence of 90-days postoperative wound infections after cardiac surgery. Eur J Cardiothorac Surg. 2003 Jan;23(1):97-102.</citation>
    <PMID>12493512</PMID>
  </reference>
  <reference>
    <citation>Eklund AM, Valtonen M, Werkkala KA. Prophylaxis of sternal wound infections with gentamicin-collagen implant: randomized controlled study in cardiac surgery. J Hosp Infect. 2005 Feb;59(2):108-12.</citation>
    <PMID>15620444</PMID>
  </reference>
  <reference>
    <citation>Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z, Kertzman V, Cohen O, Milo S. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg. 2002 Feb;123(2):326-32.</citation>
    <PMID>11828293</PMID>
  </reference>
  <reference>
    <citation>Friberg O, Svedjeholm R, Söderquist B, Granfeldt H, Vikerfors T, Källman J. Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thorac Surg. 2005 Jan;79(1):153-61; discussion 161-2.</citation>
    <PMID>15620935</PMID>
  </reference>
  <reference>
    <citation>Dickie SR, Dorafshar AH, Song DH. Definitive closure of the infected median sternotomy wound: a treatment algorithm utilizing vacuum-assisted closure followed by rigid plate fixation. Ann Plast Surg. 2006 Jun;56(6):680-5.</citation>
    <PMID>16721085</PMID>
  </reference>
  <reference>
    <citation>Hendrickson SC, Koger KE, Morea CJ, Aponte RL, Smith PK, Levin LS. Sternal plating for the treatment of sternal nonunion. Ann Thorac Surg. 1996 Aug;62(2):512-8.</citation>
    <PMID>8694615</PMID>
  </reference>
  <reference>
    <citation>Pai S, Gunja NJ, Dupak EL, McMahon NL, Roth TP, Lalikos JF, Dunn RM, Francalancia N, Pins GD, Billiar KL. In vitro comparison of wire and plate fixation for midline sternotomies. Ann Thorac Surg. 2005 Sep;80(3):962-8.</citation>
    <PMID>16122464</PMID>
  </reference>
  <reference>
    <citation>Song DH, Lohman RF, Renucci JD, Jeevanandam V, Raman J. Primary sternal plating in high-risk patients prevents mediastinitis. Eur J Cardiothorac Surg. 2004 Aug;26(2):367-72.</citation>
    <PMID>15296898</PMID>
  </reference>
  <reference>
    <citation>Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR; Society of Thoracic Surgeons. The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration. Ann Thorac Surg. 2006 Jan;81(1):397-404.</citation>
    <PMID>16368422</PMID>
  </reference>
  <reference>
    <citation>Bratzler DW, Houck PM; Surgical Infection Prevention Guidelines Writers Workgroup; American Academy of Orthopaedic Surgeons; American Association of Critical Care Nurses; American Association of Nurse Anesthetists; American College of Surgeons; American College of Osteopathic Surgeons; American Geriatrics Society; American Society of Anesthesiologists; American Society of Colon and Rectal Surgeons; American Society of Health-System Pharmacists; American Society of PeriAnesthesia Nurses; Ascension Health; Association of periOperative Registered Nurses; Association for Professionals in Infection Control and Epidemiology; Infectious Diseases Society of America; Medical Letter; Premier; Society for Healthcare Epidemiology of America; Society of Thoracic Surgeons; Surgical Infection Society. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004 Jun 15;38(12):1706-15. Epub 2004 May 26. Review.</citation>
    <PMID>15227616</PMID>
  </reference>
  <reference>
    <citation>Engelman R, Shahian D, Shemin R, Guy TS, Bratzler D, Edwards F, Jacobs M, Fernando H, Bridges C; Workforce on Evidence-Based Medicine, Society of Thoracic Surgeons. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. Ann Thorac Surg. 2007 Apr;83(4):1569-76. Review.</citation>
    <PMID>17383396</PMID>
  </reference>
  <reference>
    <citation>Bolon MK, Morlote M, Weber SG, Koplan B, Carmeli Y, Wright SB. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis. 2004 May 15;38(10):1357-63. Epub 2004 Apr 21.</citation>
    <PMID>15156470</PMID>
  </reference>
  <reference>
    <citation>Harton SC, Grap MJ, Savage L, Elswick RK. Frequency and predictors of return to incentive spirometry volume baseline after cardiac surgery. Prog Cardiovasc Nurs. 2007 Winter;22(1):7-12.</citation>
    <PMID>17342000</PMID>
  </reference>
  <reference>
    <citation>Dhadwal K, Al-Ruzzeh S, Athanasiou T, Choudhury M, Tekkis P, Vuddamalay P, Lyster H, Amrani M, George S. Comparison of clinical and economic outcomes of two antibiotic prophylaxis regimens for sternal wound infection in high-risk patients following coronary artery bypass grafting surgery: a prospective randomised double-blind controlled trial. Heart. 2007 Sep;93(9):1126-33. Epub 2007 Feb 19.</citation>
    <PMID>17309908</PMID>
  </reference>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2008</study_first_submitted>
  <study_first_submitted_qc>March 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2008</study_first_posted>
  <results_first_submitted>February 23, 2011</results_first_submitted>
  <results_first_submitted_qc>April 5, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 2, 2011</results_first_posted>
  <last_update_submitted>April 5, 2011</last_update_submitted>
  <last_update_submitted_qc>April 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Gary Moore/ Regulatory Affair, Quality Assurance</name_title>
    <organization>KLS Martin, L.P.</organization>
  </responsible_party>
  <keyword>Sternal wound closure</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>sternal nonunion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wound Infection</mesh_term>
    <mesh_term>Mediastinitis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were consented and enrolled in the study at 2 centers from April 2008 to July 2009.</recruitment_details>
      <pre_assignment_details>Overall 53 subjects were consented and enrolled in the study from April 2008 to July 2009. Two patients were not included in the analysis (1 patients’ surgery was cancelled, 1 patient was not randomized due to logistical reasons), leaving a total of 51 subjects who were included in the modified intent-to-treat analysis.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Conventional Wires Only</title>
          <description>The control group received conventional wires including double wires to close the sternum.</description>
        </group>
        <group group_id="P2">
          <title>Talon</title>
          <description>Subjects randomized to the Talon group received Talons in the sternum plus supplementary wires in the manubrium. The number of Talons inserted was based on patient factors/clinician judgment. For study subjects randomized to the Talon, the device was to be inserted/used in an identical manner to use of the Talon in non-study patients.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Conventional Wires Only</title>
          <description>The control group received conventional wires including double wires to close the sternum.</description>
        </group>
        <group group_id="B2">
          <title>Talon</title>
          <description>Subjects randomized to the Talon group received Talons in the sternum plus supplementary wires in the manubrium. The number of Talons inserted was based on patient factors/clinician judgment. For study subjects randomized to the Talon, the device was to be inserted/used in an identical manner to use of the Talon in non-study patients.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="28"/>
            <count group_id="B3" value="51"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.0" spread="9.2"/>
                    <measurement group_id="B2" value="61.8" spread="10.0"/>
                    <measurement group_id="B3" value="62.4" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage Change of Preoperative Incentive Spirometry (IS) Volume Achieved</title>
        <description>Maximum incentive spirometry volume was measured at baseline (prior to surgery) and daily from postoperative day 1 through postoperative day 7 (or discharge if earlier) using a Coach 2 incentive spirometer with one way valve (Coach 2 model # 22-4000, Smiths Medical, Keene, NH).</description>
        <time_frame>Baseline, Maximum value during postoperatively days 1 thru 7</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Conventional Wires Only</title>
            <description>The control group received conventional wires including double wires to close the sternum.</description>
          </group>
          <group group_id="O2">
            <title>Talon</title>
            <description>Subjects randomized to the Talon group received Talons in the sternum plus supplementary wires in the manubrium. The number of Talons inserted was based on patient factors/clinician judgment. For study subjects randomized to the Talon, the device was to be inserted/used in an identical manner to use of the Talon in non-study patients.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Change of Preoperative Incentive Spirometry (IS) Volume Achieved</title>
          <description>Maximum incentive spirometry volume was measured at baseline (prior to surgery) and daily from postoperative day 1 through postoperative day 7 (or discharge if earlier) using a Coach 2 incentive spirometer with one way valve (Coach 2 model # 22-4000, Smiths Medical, Keene, NH).</description>
          <units>percentage change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58" spread="24"/>
                    <measurement group_id="O2" value="67" spread="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.41</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Sternal Wound Infection or Sternal Instability/Non-union</title>
        <description>The Data and Safety Monitoring Board reviewed source documents for all cases with possible sternal wound infection and sternal instability or non-union and made a determination as to the presence of these complications.</description>
        <time_frame>Up to 180 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Conventional Wires Only</title>
            <description>The control group received conventional wires including double wires to close the sternum.</description>
          </group>
          <group group_id="O2">
            <title>Talon</title>
            <description>Subjects randomized to the Talon group received Talons in the sternum plus supplementary wires in the manubrium. The number of Talons inserted was based on patient factors/clinician judgment. For study subjects randomized to the Talon, the device was to be inserted/used in an identical manner to use of the Talon in non-study patients.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Sternal Wound Infection or Sternal Instability/Non-union</title>
          <description>The Data and Safety Monitoring Board reviewed source documents for all cases with possible sternal wound infection and sternal instability or non-union and made a determination as to the presence of these complications.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Conventional Wires Only</title>
          <description>The control group received conventional wires including double wires to close the sternum.</description>
        </group>
        <group group_id="E2">
          <title>Talon</title>
          <description>Subjects randomized to the Talon group received Talons in the sternum plus supplementary wires in the manubrium. The number of Talons inserted was based on patient factors/clinician judgment. For study subjects randomized to the Talon, the device was to be inserted/used in an identical manner to use of the Talon in non-study patients.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure</sub_title>
                <description>Randomized to Standard of Care arm</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Chest tube entrapment between sternal halves (not Talon)</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <description>Chest tube entrapped between sternal halves, but not Talon device. Surgeon considered this NOT related to study. DSMB reviewed event.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Elliott Bennett-Guerrero</name_or_title>
      <organization>Duke University</organization>
      <phone>9196819660</phone>
      <email>benne011@mc.duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

